Vera Luginbuehl

951 total citations
14 papers, 779 citations indexed

About

Vera Luginbuehl is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vera Luginbuehl has authored 14 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Vera Luginbuehl's work include Photodynamic Therapy Research Studies (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Bone Tissue Engineering Materials (4 papers). Vera Luginbuehl is often cited by papers focused on Photodynamic Therapy Research Studies (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Bone Tissue Engineering Materials (4 papers). Vera Luginbuehl collaborates with scholars based in Switzerland, Germany and United States. Vera Luginbuehl's co-authors include Hans P. Merkle, Lorenz Meinel, Bruno Gander, Martin Hefti, Brigitte von Rechenberg, Evangelos Zoidis, Annette Koch, Karin Kovar, Esther Wenk and Herbert Looser and has published in prestigious journals such as Chemistry - A European Journal, Biotechnology Advances and Pharmaceutical Research.

In The Last Decade

Vera Luginbuehl

13 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Luginbuehl Switzerland 13 463 165 141 136 127 14 779
Jacqui McGovern Australia 19 480 1.0× 148 0.9× 203 1.4× 230 1.7× 79 0.6× 44 1.0k
Richard Ngo United States 5 351 0.8× 99 0.6× 206 1.5× 175 1.3× 133 1.0× 9 690
Vincent M.J.I. Cuijpers Netherlands 18 629 1.4× 248 1.5× 321 2.3× 227 1.7× 172 1.4× 35 1.3k
Shengwei Han China 13 563 1.2× 155 0.9× 194 1.4× 332 2.4× 54 0.4× 20 1.0k
Disheng Yang China 16 256 0.6× 95 0.6× 205 1.5× 125 0.9× 43 0.3× 60 759
Zhouming Deng China 19 438 0.9× 153 0.9× 138 1.0× 330 2.4× 49 0.4× 30 951
Jun Ohno Japan 17 281 0.6× 98 0.6× 117 0.8× 252 1.9× 58 0.5× 59 748
Ying Xue Norway 21 616 1.3× 268 1.6× 286 2.0× 202 1.5× 135 1.1× 49 1.2k
Ajaykumar Vishwakarma United States 6 375 0.8× 205 1.2× 227 1.6× 279 2.1× 43 0.3× 6 1.1k
Joachim Aigner Germany 16 278 0.6× 263 1.6× 342 2.4× 174 1.3× 144 1.1× 22 861

Countries citing papers authored by Vera Luginbuehl

Since Specialization
Citations

This map shows the geographic impact of Vera Luginbuehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Luginbuehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Luginbuehl more than expected).

Fields of papers citing papers by Vera Luginbuehl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Luginbuehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Luginbuehl. The network helps show where Vera Luginbuehl may publish in the future.

Co-authorship network of co-authors of Vera Luginbuehl

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Luginbuehl. A scholar is included among the top collaborators of Vera Luginbuehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Luginbuehl. Vera Luginbuehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Luginbuehl, Vera, et al.. (2022). Better by design: What to expect from novel CAR-engineered cell therapies?. Biotechnology Advances. 58. 107917–107917. 21 indexed citations
2.
Luginbuehl, Vera, et al.. (2018). Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy. Biotechnology Advances. 36(3). 613–623. 29 indexed citations
3.
Luginbuehl, Vera, et al.. (2015). In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation. Journal of Tissue Engineering and Regenerative Medicine. 11(7). 1974–1985. 33 indexed citations
4.
Naik, Anu, Riccardo Rubbiani, José Marı́a Mateos, et al.. (2014). (Metallo)porphyrins as Potent Phototoxic Anti‐Cancer Agents after Irradiation with Red Light. Chemistry - A European Journal. 21(3). 1179–1183. 73 indexed citations
5.
Hefti, Martin, et al.. (2014). Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapyin vitro. Neurological Research. 36(11). 1001–1010. 23 indexed citations
6.
Luginbuehl, Vera, Evangelos Zoidis, Lorenz Meinel, et al.. (2013). Impact of IGF-I release kinetics on bone healing: A preliminary study in sheep. European Journal of Pharmaceutics and Biopharmaceutics. 85(1). 99–106. 19 indexed citations
7.
Hefti, Martin, et al.. (2012). Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells. Journal of Neuro-Oncology. 108(3). 443–450. 36 indexed citations
8.
Luginbuehl, Vera, et al.. (2011). 5-Aminolevulinic acid induced photodynamic therapy in migratory glioma cells. Photodiagnosis and Photodynamic Therapy. 8(2). 166–166. 1 indexed citations
9.
Luginbuehl, Vera, et al.. (2011). Preparing Poly (Lactic-co-Glycolic Acid) (PLGA) Microspheres Containing Lysozyme-Zinc Precipitate Using a Modified Double Emulsion Method.. PubMed. 10(2). 203–9. 15 indexed citations
10.
Hefti, Martin, et al.. (2010). Susceptibility to 5‐Aminolevulinic Acid Based Photodynamic Therapy in WHO I Meningioma Cells Corresponds to Ferrochelatase Activity. Photochemistry and Photobiology. 87(1). 235–241. 43 indexed citations
11.
Luginbuehl, Vera, et al.. (2009). Controlled release of tetracycline from biodegradable β‐tricalcium phosphate composites. Journal of Biomedical Materials Research Part B Applied Biomaterials. 92B(2). 341–352. 27 indexed citations
12.
Luginbuehl, Vera, Esther Wenk, Annette Koch, et al.. (2005). Insulin-like Growth Factor I—Releasing Alginate-Tricalciumphosphate Composites for Bone Regeneration. Pharmaceutical Research. 22(6). 940–950. 65 indexed citations
13.
Luginbuehl, Vera, Lorenz Meinel, Hans P. Merkle, & Bruno Gander. (2004). Localized delivery of growth factors for bone repair. European Journal of Pharmaceutics and Biopharmaceutics. 58(2). 197–208. 273 indexed citations
14.
Meinel, Lorenz, Evangelos Zoidis, Jürgen Zapf, et al.. (2003). Localized insulin-like growth factor I delivery to enhance new bone formation. Bone. 33(4). 660–672. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026